This page only shows primary logo variants. For other related logos and images, see:
|
Vioxx was a brand of the drug rofecoxib marketed by Merck & Co. internationally between 1999 and 2004. It was marketed by the company as a prescribed medicine to treat acute pain, arthritis, migraines, and other sicknesses. In 2004, Merck & Co. withdrew Vioxx from markets internationally. It would later be revealed that they withdrew the drug after disclosures that the company withheld information from doctors and patients about Vioxx causing an increased risk of heart attack and stroke.
Research conducted after the drug was recalled and discontinued in 2004 estimates that it had likely caused around 40,000 to 60,000 deaths in the United States and 4,000 to 7,000 deaths in Canada. One FDA analyst stated that Vioxx may have caused 88,000 to 139,000 patients taking the drug to have heart attacks in the United States, with 30 to 40 percent of which likely being fatal.
1999–2004 (United States)[]
1999–2004 (international)[]
See also[]
- Arcoxia, a "successor" drug also made by Merck & Co..
- Bextra, a similar drug which was recalled and discontinued in 2005.
External links[]
| Subsidiaries Acceleron Pharma | Cubist Pharmaceuticals | H. K. Mulford Company | Schering-Plough | Viralytics | Merck Sharp & Dohme Current pharmaceutical products Former/defunct assets  |